BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yue L, Shi Y, Su X, Ouyang L, Wang G, Ye T. Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectives. Eur J Med Chem 2021;224:113714. [PMID: 34315043 DOI: 10.1016/j.ejmech.2021.113714] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Xie Y, Yue L, Shi Y, Su X, Gan C, Liu H, Xue T, Ye T. Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future Perspectives. J Med Chem 2023. [PMID: 36940432 DOI: 10.1021/acs.jmedchem.2c01753] [Reference Citation Analysis]
2 Hayun H, Coban M, Bhagat AK, Ozer E, Alfonta L, Caulfield TR, Radisky ES, Papo N. Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14. Res Sq 2023:rs. [PMID: 36712032 DOI: 10.21203/rs.3.rs-2446107/v1] [Reference Citation Analysis]
3 Takeuchi T, Nomura Y, Tamita T, Nishikawa R, Kakinuma H, Kojima N, Hitaka K, Tamura Y, Kamitani M, Mima M, Nozoe A, Hayashi M. Discovery of TP0597850: A Selective, Chemically Stable, and Slow Tight-Binding Matrix Metalloproteinase-2 Inhibitor with a Phenylbenzamide-Pentapeptide Hybrid Scaffold. J Med Chem 2023;66:822-36. [PMID: 36595440 DOI: 10.1021/acs.jmedchem.2c01698] [Reference Citation Analysis]
4 Ma H, Wu X, Li Y, Xia Y. Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis. Front Pharmacol 2022;13:963054. [DOI: 10.3389/fphar.2022.963054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Hayun H, Arkadash V, Sananes A, Arbely E, Stepensky D, Papo N. Bioorthogonal PEGylation Prolongs the Elimination Half-Life of N-TIMP2 While Retaining MMP Inhibition. Bioconjug Chem 2022. [PMID: 35446024 DOI: 10.1021/acs.bioconjchem.2c00059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Якупова Э, Зоров Д, Плотников Е. Биоэнергетика фиброза. БМ 2021;86:1865-1874. [DOI: 10.31857/s0320972521120101] [Reference Citation Analysis]
7 Yakupova EI, Zorov DB, Plotnikov EY. Bioenergetics of the Fibrosis. Biochemistry (Mosc) 2021;86:1599-606. [PMID: 34937539 DOI: 10.1134/S0006297921120099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Xue T, Qiu X, Liu H, Gan C, Tan Z, Xie Y, Wang Y, Ye T. Epigenetic regulation in fibrosis progress. Pharmacol Res 2021;173:105910. [PMID: 34562602 DOI: 10.1016/j.phrs.2021.105910] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]